Active, not recruitingNCT05742217

A Study to Learn How Patients With Triple Class Refractory Multiple Myeloma (TCR-MM) Are Treated in Italian Centers for Blood Related Diseases

Studying Multiple myeloma

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Pfizer
Principal Investigator: Pfizer CT.gov Call Center
Pfizer
Enrollment: 250 enrolled
Eligibility: 18 years · All sexes
Timeline: 2023 – 2026

Study locations (19)

A.O.U. - Ospedali Riuniti di Ancona, Torrette, Aviano, Italy
A.O.U. Policlinico S.Orsola Malpighi, Bologna, BO, Italy
"IRCCS "" Casa Sollievo della Sofferenza""tOpera di San Pio da Pietrelcina U.O.C di Ematologia", San Giovanni Rotondo, Foggia, Italy
AOU Policlinico Umberto I, Rome, Lazio, Italy
Fondazione IRCCS Policlinico Sa Matteo U.O.C. Ematologia, Pavia, Lombardy, Italy
A.O.U Policlinico G. Rodolico S. Marco, Catania, Sicily, Italy
A.O.U. Policlinico Paolo Giaccone, Palermo, Sicily, Italy
A.O.O.R. Villa Sofia Cervello, U.O. Oncoematologia, Palermo, Sicily, Italy
Azienda Ospedaliera Universitaria Careggi, Florence, Italy
IRST, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola (FC), Italy
A.O.U. Policlinico Università degli Studi di Napoli "Federico II", Naples, Italy
Azienda Ospedaliero-Universitaria Maggiore della Carita, Novara, Italy
Azienda Ospedaliero - Universitaria Di Parma, Parma, Italy
Ospedale Civile dello Spirito Santo, Pescara, Italy
Arcispedale Santa Maria Nuova, Reggio Emilia, Italy
+4 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05742217 on ClinicalTrials.gov

Other trials for Multiple myeloma

Additional recruiting or active studies for the same condition.

See all trials for Multiple myeloma →

← Back to all trials